StockData
Medifast Inc logo

Medifast Inc (MED) company profile

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3057% below fair value
$12.19−0.35 (-2.79%)

Close on Nov 17, 2026Market cap $136.32MP/E –Yield 0.00%

About Medifast

Miscellaneous Food Preparations & Kindred Products, SIC 2090

Medifast, Inc. provides coach-guided health, wellness, and lifestyle solutions centered on metabolic health and weight management. The company offers structured nutrition programs, such as its 5 & 1 and Optimal Weight plans, alongside proprietary food and nutritional product lines including OPTA VIA Fuelings, OPTA VIA ACTIVE, and OPTA VIA ASCEND. Its offerings combine scientifically formulated pre-portioned meal replacements, dietary supplements, habit-change blueprints, community support, and a companion mobile application. Medifast serves individual consumers seeking weight reduction, long-term weight maintenance, and metabolic wellness, including individuals who use weight-loss medications.

The company distributes its products and lifestyle plans directly to consumers through an independent network of approximately 16,100 active earning coaches as of late 2025. It targets clients primarily across the United States and operates through domestic and international subsidiaries, including entities registered in Hong Kong and Shanghai. The company's provided filing text does not disclose a specific headquarters location.

Summary of the business section of Medifast's latest annual report, written by StockData.

Company profile

Company

Legal name
Medifast Inc
Founded
1980
Headquarters
Baltimore, MD
Address
1501 S. Clinton Street, Suite 500 21224
Phone
(410) 581-8042
Employees
380, Dec 31, 2025
Industry
Miscellaneous Food Preparations & Kindred Products
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
RSM US LLP, Baltimore, Maryland

Stock & identifiers

Ticker
MED
Exchange
NYSE
IPO date
Dec 30, 1993
Shares outstanding
11M, Oct 19, 2026
Public float
$145.00M, Jun 30, 2025
Filer category
Accelerated filer<br>Smaller reporting company
SEC CIK
910329
CUSIP
58470H101
ISIN
US58470H1014
FIGI
BBG000BWBW76
Share class FIGI
BBG001SD45H4
LEI
5299000YHQJ21T5KKI80
EIN
13-3714405

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Nicholas Mark JohnsonPresident13,457
Jonathan Barrett MacKenzieVP, Finance & CAO20,838
James P. MaloneyChief Financial Officer37,675
Parsa KiaiDirector32,769
Daniel R. ChardDirector336,520
Jeffrey Matthew RoseDirector11,680
Scott SchlackmanDirector42,229
Ming XianDirector–
Andrea B. ThomasDirector35,697
Elizabeth A. GearyDirector31,225
Michael A. HoerDirector26,139
Jeffrey J. BrownDirector33,361

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$5.58M$2.73M$1.32M$6$116
FY2024$5.61M$983.51K$1.16M$10$140
FY2023$7.04M$2.93M$1.74M$39$139
FY2022$5.94M-$710.74K$1.23M$63$120
FY2021$6.57M$12.94M$1.44M$109$129
FY2020$5.54M$9.91M$951.88K$186$111

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Daniel R. Chard
Chairman & Chief Executive Officer
$1.00M$4.57M$0$16.89K$5.58M-0%
James P. Maloney
Chief Financial Officer
$527.09K$700.43K$184.48K$16.40K$1.43M+6%
Nicholas M. Johnson
Chief Field Operations Officer
$440.35K$585.16K$154.12K$15.98K$1.20M+6%
Anthony E. Tyree
Former Chief Business Operations Officer (2)
$415.87K$162.19K$145.56K$761.10K$1.48M+39%
Jason L. Groves
Chief Legal Officer & Corporate Secretary
$427.78K$568.47K$149.72K$14.48K$1.16M+6%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we employed 380 team members, all employed in the United States, of whom 173 were engaged in manufacturing, logistics and supply chain support, and 207 in marketing, administrative and corporate support functions.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?